Press "Enter" to skip to content

Albuquerque-based company lands patent for novel Alzheimer's technology

The approval is for a “method patent,” said Kristina Trujillo, TNeuroPharma’s CEO. It’s licensed exclusively to TNeuroPharma for the company’s method of detecting T-cells in patients to diagnose and treat Alzheimer’s.
Source: The Business Journal

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *